BF
NVCR icon

BOK Financial’s NovoCure NVCR Stock Holding History

BOK Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70
Closed -$1.04K – 1290
2023
Q4 		$1.04K Buy
+70
New +$937 ﹤0.01% 1148
2020
Q2 		– Sell
-24,606
Closed -$1.66M – 876
2020
Q1 		$1.66M Buy
24,606
+6,008
+32% +$475K 0.05% 324
2019
Q4 		$1.57M Buy
+18,598
New +$1.5M 0.04% 409

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOK Financial's NVCR Position: Q1 2024 in Review

BOK Financial sold out of NovoCure (NVCR) in Q1 2024, closing a stake of 70 shares — an estimated $1.04K sold.

BOK Financial first reported a position in NVCR in Q4 2019 and held it in 3 quarters. The position peaked at $1.66M in Q1 2020. 237 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

  • BOK Financial reported no remaining NovoCure position as of Q1 2024 after selling out during the quarter.
  • BOK Financial sold 70 NovoCure shares in Q1 2024, an estimated $1.04K.
  • BOK Financial first reported a position in NovoCure in Q4 2019 and held it in 3 quarters.
  • BOK Financial's NovoCure position peaked at $1.66M in Q1 2020.
  • 237 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on BOK Financial's 13F filing for Q1 2024, filed 15 May 2024.